Beam Therapeutics Inc.

Pharmaceutical and biological preparations based on base editing, base modification, nucleobase editing, nucleobase modification, nucleic acid editing, gene editing, gene modification, gene modulation, gene reprogramming, gene therapy, genome editing, genome modification, cell therapy, cellular modification, tissue modification, and organ modification for use in human therapeutics for the treatment of Sickle Cell Disease, Beta Thalassemia, Alpha-1 Antitrypsin Deficiency, Glycogen Storage Disease Ia, Cancer, T-Cell Cancer, T-Cell Acute Lymphoblastic Leukemia, CD7 positive Acute Myeloid Leukemia, and Stargardt Disease; "THERAPEUTICS"

Pharmaceutical and biological preparations based on base editing, base modification, nucleobase editing, nucleobase modification, nucleic acid editing, gene editing, gene modification, gene modulation, gene reprogramming, gene therapy, genome editing, genome modification, cell therapy, cellular modification, tissue modification, and organ modification for use in human therapeutics for the treatment of Sickle Cell Disease, Beta Thalassemia, Alpha-1 Antitrypsin Deficiency, Glycogen Storage Disease Ia, Cancer, T-Cell Cancer, T-Cell Acute Lymphoblastic Leukemia, CD7 positive Acute Myeloid Leukemia, and Stargardt Disease; "THERAPEUTICS"

Class 042: Scientific and medical research in the fields of base editing, base modification, base repair, nucleobase editing, nucleobase modification, nucleobase repair, nucleic acid editing, gene editing, gene modification, gene modulation, gene reprogramming, genome editing, genome modification, cellular modification, tissue modification, organ modification; providing scientific and medical research information, and bioinformatic algorithms and models in the fields of base editing, base modification, base repair, nucleobase editing, nucleobase modification, nucleobase repair, nucleic acid editing, gene editing, gene modification, gene modulation, gene reprogramming, genome editing, genome modification, cellular modification, tissue modification, organ modification; scientific study and research in the fields of base editing, base modification, base repair, nucleobase editing, nucleobase modification, nucleobase repair, nucleic acid editing, gene editing, gene modification, gene modulation, gene reprogramming, genome editing, genome modification, cellular modification, tissue modification, organ modification to develop human pharmaceutical and biological preparations

Class 042: Scientific and medical research in the fields of base editing, base modification, base repair, nucleobase editing, nucleobase modification, nucleobase repair, nucleic acid editing, gene editing, gene modification, gene modulation, gene reprogramming, genome editing, genome modification, cellular modification, tissue modification, organ modification; providing scientific and medical research information, and bioinformatic algorithms and models in the fields of base editing, base modification, base repair, nucleobase editing, nucleobase modification, nucleobase repair, nucleic acid editing, gene editing, gene modification, gene modulation, gene reprogramming, genome editing, genome modification, cellular modification, tissue modification, organ modification; scientific study and research in the fields of base editing, base modification, base repair, nucleobase editing, nucleobase modification, nucleobase repair, nucleic acid editing, gene editing, gene modification, gene modulation, gene reprogramming, genome editing, genome modification, cellular modification, tissue modification, organ modification to develop human pharmaceutical and biological preparations